Research leaders voiced concerns about attacks on diversity efforts, grant terminations, and fear among scientists at #STATBreakthrough.

Elizabeth Holmes had more resources, talent, and opportunity than most founders will ever see — and she blew it. Now, writes ...

In a world first, scientists used CRISPR to fix a baby's unique genetic mutation. The report offers hope for personalized ...

A top agency official is meeting with industry and FDA staff as he works on guidance clarifying the FDA’s expectations for ...

Republicans on the House Appropriations Committee lauded the Make America Healthy Again movement on Wednesday while pushing ...

Lurking beneath the shiny promise of artificial intelligence in health care is a host of potential liability issues, experts ...

CMS and ASTP, the health department’s health IT regulator, released a request for information this week about existing ...

Meanwhile, at STAT’s Breakthrough Summit West in San Francisco, former FDA Commissioner Robert Califf criticized RFK Jr.’s ...

Good morning! Despite believing that headlines on STAT stories are “terrible,” former FDA head Robert Califf said at ...

Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...

Biotech investors are preparing for what may be the most important clinical trial readout for them this summer.

Lowering drug prices to European benchmarks would ultimately reduce innovation and cost American consumers just over half a ...